Roche Holding (RHHBY)
(Delayed Data from OTC)
$30.25 USD
+0.23 (0.77%)
Updated Apr 26, 2024 04:00 PM ET
4-Sell of 5 4
C Value C Growth D Momentum C VGM
Income Statements
Fiscal Year end for Roche Holding AG falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 67,325 | 69,608 | 72,046 | 64,362 | 64,165 |
Cost Of Goods | 18,220 | 21,374 | 21,496 | 17,254 | 18,470 |
Gross Profit | 49,105 | 48,234 | 50,551 | 47,107 | 45,695 |
Selling & Adminstrative & Depr. & Amort Expenses | 31,957 | 29,921 | 30,687 | 27,329 | 28,033 |
Income After Depreciation & Amortization | 17,148 | 18,313 | 19,863 | 19,778 | 17,662 |
Non-Operating Income | -356 | -507 | -371 | -27 | 59 |
Interest Expense | 1,109 | 697 | 457 | 590 | 999 |
Pretax Income | 15,683 | 17,109 | 19,035 | 19,161 | 16,722 |
Income Taxes | 1,917 | 2,930 | 2,695 | 3,090 | 2,522 |
Minority Interest | 958 | 1,163 | 1,100 | 824 | 615 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 13,766 | 14,179 | 16,340 | 16,072 | 14,200 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 12,808 | 13,016 | 15,241 | 15,247 | 13,585 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 21,007 | 22,341 | 24,724 | 24,640 | 21,982 |
Depreciation & Amortization (Cash Flow) | 3,859 | 4,028 | 4,861 | 4,862 | 4,320 |
Income After Depreciation & Amortization | 17,148 | 18,313 | 19,863 | 19,778 | 17,662 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 6,427.95 | 6,464.00 | 6,879.01 | 6,920.00 | 6,912.00 |
Diluted EPS Before Non-Recurring Items | 2.58 | 2.66 | 2.71 | 2.65 | 2.54 |
Diluted Net EPS (GAAP) | 1.99 | 2.01 | 2.22 | 2.20 | 1.97 |
Fiscal Year end for Roche Holding AG falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |